Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

TNXP Tonix Pharmaceuticals Holding Corporation

0,43

0,00 (0,00%)

30 Jan 2025 - Geschlossen

Verzögert um 15 Minuten

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

null

Tonix Pharmaceuticals (NASDAQ:TNXP)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Tonix Pharmaceuticals Charts.

Tonix Pharmaceuticals (NASDAQ:TNXP)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Tonix Pharmaceuticals Charts.

News Tonix Pharmaceuticals Holding Corporation

Form 8-K - Current report
Mittwoch 8 Januar 2025 (3 Wochen vor) • Edgar (US Regulatory)

Tonix Pharmaceuticals Further Strengthens Commercial Leadership Team with Appointment of Gary Ainsworth as Vice President of Market Access
Mittwoch 8 Januar 2025 (3 Wochen vor) • GlobeNewswire Inc.

Tonix Pharmaceuticals to Present at Two Upcoming January Investor Conferences
Dienstag 7 Januar 2025 (3 Wochen vor) • GlobeNewswire Inc.

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Freitag 3 Januar 2025 (4 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 23 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Tonix Pharmaceuticals Announces PDUFA Goal Date of August 15, 2025, for FDA Decision on U.S. Marketing Approval for TNX-102 SL for Fibromyalgia
Montag 23 Dezember 2024 (1 Monat vor) • GlobeNewswire Inc.

Form 8-K - Current report
Freitag 20 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Freitag 20 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

This Micro Cap Is Getting Bid Up Prior To Opening Bell
Dienstag 17 Dezember 2024 (1 Monat vor) • AllPennyStocks.com

Form 8-K - Current report
Dienstag 17 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Tonix Pharmaceuticals Announces FDA Acceptance of the New Drug Application (NDA) for TNX-102 SL for Fibromyalgia
Dienstag 17 Dezember 2024 (1 Monat vor) • GlobeNewswire Inc.

Form S-8 - Securities to be offered to employees in employee benefit plans
Freitag 6 Dezember 2024 (2 Monate vor) • Edgar (US Regulatory)

Weitere Tonix Pharmaceuticals Holding Corporation News-Artikel

European Investment Bank

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen